의약품유통협 신년회…조선혜 회장 “마부작침” 강조

글 내용 전체보기

Clinical Trial Launches to Develop Breath Test for Multiple Cancers

글 내용 전체보기

Toft Group Executive Search Announces New San Francisco Bay Area Headquarters

글 내용 전체보기

Puma Biotechnology to Present at J. P. Morgan Healthcare Conference

글 내용 전체보기

Novartis Provides Data to SPARK, Pew’s Platform for Antibiotic Discovery Research

글 내용 전체보기

Live Better, Feel Better: Youfit Health Clubs Hosts National Open House to Kick off the New Year

글 내용 전체보기

Phyton Biotech Partners with Agenus to Revolutionize QS-21 Production

글 내용 전체보기

Senzer’s Unique Pharmaceutical Inhaler Wins Prestigious Global Design Award

글 내용 전체보기

Teva and Amgen Resolve Ongoing Dispute Over Teva’s Generic Cinacalet HCl Product

글 내용 전체보기

Mark Hensley Promoted to Chief Commercial Officer of Veloxis Pharmaceuticals

글 내용 전체보기

Ascletis’ IND Filing for Its Third HCV Drug ASC21 Accepted by NMPA

글 내용 전체보기

Ohr Pharma and NeuBase Merge to Push NeuBase’s Rare Disease Tech Platform

글 내용 전체보기

AstraZeneca Spinoff Viela Bio Reports Positive Phase IIb Trial in Rare Disease

글 내용 전체보기

UroGen Taps Oncology Veteran Elizabeth Barrett as Its New CEO

글 내용 전체보기

Tiburio Launches With $31 Million and Two Compounds From Ipsen Targeting Rare Endocrine Diseases

글 내용 전체보기

Tiburio Launches With $31 Million and Two Compounds From Ipsen Targeting Rare Endocrine Diseases

글 내용 전체보기

Merck Licenses NASH Compound From NGM Biopharma for $20 Million

글 내용 전체보기

The 20 Hottest Pipeline Drugs to Watch in 2019

글 내용 전체보기

Locus and Janssen Ink Potential $818 Million Deal to Develop CRISPR-Based Antibacterials

글 내용 전체보기

A Look at the Year’s Most and Least Successful Biotech IPOs

글 내용 전체보기

Takeda Drives Immuno-Oncology Portfolio With Three Cell Therapy Collaborations

글 내용 전체보기